Strides Arcolab stronger than Orchid Chemicals: Seshadri Bharatan
Seshadri Bharatan, Investment Analyst, in a chat with ET Now, talks about pharma stocks.
At this point of time, I am more inclined towards Strides Arcolab. We have seen that last week one of their generated drugs was approved by US FDA. So yes, there are lot of streams of income being built in as the generic market opens for some of these companies and Strides Arcolab among these two is showing more strength on the charts compared to Orchid Chemicals.
Download ET Markets APP